临床药师参与心内科老年患者会诊情况调查及典型案例分析
|
摘要
目的调查焦作市第二人民医院临床药师参与心内科老年患者的会诊情况并分享典型案例,为进一步提高临床药学服务提供参考。方法收集焦作市第二人民医院2017年1月—2018年6月临床药师会诊或主动监护的心内科老年患者的药物使用情况及典型案例进行分析。结果临床药师共参与心内科老年患者会诊或主动监护病例57例,会诊常见疾病为高血压、心律失常、冠心病等,会诊常见药物为抗高血压药物、抗菌药物、抗心律失常药物等,会诊意见采纳率为78.95%(完全采纳43.86%,部分采纳35.09%),会诊意见有效率为75.44%。结论临床药师应积极参与临床实践,与医师形成一个治疗团队,及时发现并解决用药中出现的问题,促进临床合理用药。
OBJECTIVE To investigate the consultation of clinical pharmacists in the Second People's Hospital of Jiaozuo City for elderly patients with cardiology and share typical cases, and to provide reference for further improving clinical pharmacy services. METHODS To analyze the drug use and typical cases of elderly patients with cardiology in the clinical pharmacist consultation or active monitoring from January 2017 to June 2018 in the Second People's Hospital of Jiaozuo City. RESULTS Clinical pharmacists participated in 57 cases of consultation or active monitoring of elderly patients in cardiology. The common diseases were hypertension, arrhythmia, coronary heart disease, etc. The common drugs for consultation were antihypertensive drugs, antibacterial drugs, antiarrhythmic drugs, etc. The consultation rate was 78.95%(completely adopted 43.86%, partially adopted 35.09%), the effective rate of consultation was 75.44%. CONCLUSION Clinical pharmacists should actively participate in clinical practice, form a treatment team with physicians, timely discover and solve problems in medication, and promote clinical rational drug use.
OBJECTIVE To investigate the consultation of clinical pharmacists in the Second People's Hospital of Jiaozuo City for elderly patients with cardiology and share typical cases, and to provide reference for further improving clinical pharmacy services. METHODS To analyze the drug use and typical cases of elderly patients with cardiology in the clinical pharmacist consultation or active monitoring from January 2017 to June 2018 in the Second People's Hospital of Jiaozuo City. RESULTS Clinical pharmacists participated in 57 cases of consultation or active monitoring of elderly patients in cardiology. The common diseases were hypertension, arrhythmia, coronary heart disease, etc. The common drugs for consultation were antihypertensive drugs, antibacterial drugs, antiarrhythmic drugs, etc. The consultation rate was 78.95%(completely adopted 43.86%, partially adopted 35.09%), the effective rate of consultation was 75.44%. CONCLUSION Clinical pharmacists should actively participate in clinical practice, form a treatment team with physicians, timely discover and solve problems in medication, and promote clinical rational drug use.
引文
[1]DUAN R,LI Z X.Analysis on influencing factors of potentially inappropriate medication of elderly patients in Tianjin Medical University General Hospital for six months[J].Drug Evaluat Res(药物评价研究),2018,41(4):664-670.
[2]CHEN Z Y,LI F,ZHAO Z G,et al.The research progress of pharmacists participating in polypharmacy management in elderly patients[J].Chin J Hosp Pharm(中国医院药学杂志),2018,38(4):450-453.
[3]SUN Y P,CAI Y,LYU J J,et al.Practice and experience of clinical pharmacists in the multidisciplinary team of senile dementia department[J].Chin J New Drugs(中国新药杂志),2018,27(2):245-248.
[4]TANG S Y,LIU T T,JIANG X,et al.Analysis of clinical pharmacists participating in 300 cases of children antibacterial drugs consultation in our hospital during 2011-2013[J].China Pharm(中国药房),2014,25(46):4404-4408.
[5]SUN B,SHI W F,LI X N,et al.Practice of clinical pharmacists in the drug therapy of in orthopedics ward[J].China Pharmacist(中国药师),2018,21(5):875-878.
[6]ZHOU H Q,CHEN G D.Pharmacological care for hypertension patients with diabetes by clinical pharmacists[J].Evaluat Anal Drugs Used Hosp Chin(中国医院用药评价与分析),2018,18(3):418-420.
[7]国家卫生计生委合理用药专家委员会,中国药师协会.急性ST段抬高型心肌梗死溶栓治疗的合理用药指南[J].中国医学前沿杂志(电子版),2016,8(8):25-41.
[8]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.硝酸酯在心血管疾病中规范化应用的专家共识[J].中华心血管病杂志,2010,38(9):770-774.
[9]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑血管病一级预防指南2015[J].中华神经科杂志,2015,48(8):629-643.
[10]中国老年学和老年医学学会心脑血管病专业委员会,中国医师协会心血管内科医师分会.老年高血压的诊断与治疗中国专家共识(2017版)[J].中华内科杂志,2017,56(11):885-893.
[11]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.成人感染性心内膜炎预防、诊断和治疗专家共识[J].中华心血管病杂志,2014,42(10):806-816.
[12]中华医学会外科学分会血管外科学组.深静脉血栓形成的诊断和治疗指南(第三版)[J].中华普通外科杂志,2017,32(9):807-812.
[13]中华医学会外科学分会血管外科学组.腹主动脉瘤诊断与治疗指南[J].中国实用外科杂志,2008,28(11):916-918.
[14]BIAN Y,LONG E W,WU X W,et al.Application of 2014STOPP/START criteria in evaluating inappropriateness of cardiovascular system drugs prescribed in hospitalized elderly patients[J].Chin J New Drugs Clin Rem(中国新药与临床杂志),2017,36(2):107-113.
[15]姜玲,史天陆.肾功能不全患者治疗临床药师指导手册[M].北京:人民卫生出版社,2014:52.
[16]DU M X,LIU X Q,YANG M,et al.Analysis of off-label drug use in cardiovascular drugs[J].Pharm Today(今日药学),2016,26(7):515-518.
[17]LIAO L.Analysis of one case of clinical pharmacist participating in the consultation for anti-epileptic in pregnancy[J].Chin J Mod Appl Pharm(中国现代应用药学),2018,35(4):591-593.
[2]CHEN Z Y,LI F,ZHAO Z G,et al.The research progress of pharmacists participating in polypharmacy management in elderly patients[J].Chin J Hosp Pharm(中国医院药学杂志),2018,38(4):450-453.
[3]SUN Y P,CAI Y,LYU J J,et al.Practice and experience of clinical pharmacists in the multidisciplinary team of senile dementia department[J].Chin J New Drugs(中国新药杂志),2018,27(2):245-248.
[4]TANG S Y,LIU T T,JIANG X,et al.Analysis of clinical pharmacists participating in 300 cases of children antibacterial drugs consultation in our hospital during 2011-2013[J].China Pharm(中国药房),2014,25(46):4404-4408.
[5]SUN B,SHI W F,LI X N,et al.Practice of clinical pharmacists in the drug therapy of in orthopedics ward[J].China Pharmacist(中国药师),2018,21(5):875-878.
[6]ZHOU H Q,CHEN G D.Pharmacological care for hypertension patients with diabetes by clinical pharmacists[J].Evaluat Anal Drugs Used Hosp Chin(中国医院用药评价与分析),2018,18(3):418-420.
[7]国家卫生计生委合理用药专家委员会,中国药师协会.急性ST段抬高型心肌梗死溶栓治疗的合理用药指南[J].中国医学前沿杂志(电子版),2016,8(8):25-41.
[8]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.硝酸酯在心血管疾病中规范化应用的专家共识[J].中华心血管病杂志,2010,38(9):770-774.
[9]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国脑血管病一级预防指南2015[J].中华神经科杂志,2015,48(8):629-643.
[10]中国老年学和老年医学学会心脑血管病专业委员会,中国医师协会心血管内科医师分会.老年高血压的诊断与治疗中国专家共识(2017版)[J].中华内科杂志,2017,56(11):885-893.
[11]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.成人感染性心内膜炎预防、诊断和治疗专家共识[J].中华心血管病杂志,2014,42(10):806-816.
[12]中华医学会外科学分会血管外科学组.深静脉血栓形成的诊断和治疗指南(第三版)[J].中华普通外科杂志,2017,32(9):807-812.
[13]中华医学会外科学分会血管外科学组.腹主动脉瘤诊断与治疗指南[J].中国实用外科杂志,2008,28(11):916-918.
[14]BIAN Y,LONG E W,WU X W,et al.Application of 2014STOPP/START criteria in evaluating inappropriateness of cardiovascular system drugs prescribed in hospitalized elderly patients[J].Chin J New Drugs Clin Rem(中国新药与临床杂志),2017,36(2):107-113.
[15]姜玲,史天陆.肾功能不全患者治疗临床药师指导手册[M].北京:人民卫生出版社,2014:52.
[16]DU M X,LIU X Q,YANG M,et al.Analysis of off-label drug use in cardiovascular drugs[J].Pharm Today(今日药学),2016,26(7):515-518.
[17]LIAO L.Analysis of one case of clinical pharmacist participating in the consultation for anti-epileptic in pregnancy[J].Chin J Mod Appl Pharm(中国现代应用药学),2018,35(4):591-593.